Search Results

Displaying Results 76-78 of 78 "'AIC'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (2020-2034) | DelveInsight

Sep 24, 2025, 17:31 ET Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (2020-2034) | DelveInsight

emerging therapies, such as Gensco Pharma, IntelGenx, Cali Biosciences, PainReform, Oculis Pharma, MedinCell, Arthritis Innovation Corporation (AIC), Neumentum, Tris Pharma, Viatris, Xgene Pharmaceutical, Taiwan Liposome Company (TLC BioSciences), Allodynic Therapeutics, Latigo Biotherapeutics,

More news about: DelveInsight Business Research, LLP

Sep 17, 2025, 09:00 ET Symmetry Partners Selects SEI's Advisors' Inner Circle Fund to Launch First ETF

127 funds.2 SEI helped pioneer the series trust concept more than 30 years ago by introducing the AIC with an institutional-quality turnkey mutual fund operating platform. Today, the AIC enables investment organizations to rapidly launch and grow mutual funds, ETFs, and interval and tender offer

More news about: SEI Investments Company

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.